RELATED STUDY
The Current and Potential Application of Medicinal Cannabis Products in Dentistry
Key Findings: This review covers the available research on the use of phyto- and synthetic cannabinoids and the role of the endocannabinoid system in a multitude of oral and periodontal diseases. Overall cannabis and cannabidiol specifically appear to have promising anti-inflammatory, anti-infective, and analgesic effects but the rigor of the evidence is currently lacking. Future research may provide therapeutic options in the management of dental diseases.
Type of Study: Meta-analysis
Study Result: Positive
Study Location(s): Canada, Jamaica, United States
Year of Pub: 2021
Cannabinoids Studied: Cannabichromene (CBC), Cannabidiol (CBD), Cannabigerol (CBG), Tetrahydrocannabinol (THC), AM-x Synthetic Cannabinoids, JWH-x Synthetic Cannabinoids, HU-x Synthetic Cannabinoids, WIN-x Synthetic Cannabinoids, Anandamide (AEA), Cannabinoid (unspecified), Endocannabinoid (unspecified), Pharma THC, Tetrahydrocannabivarin (THCV), Cannabidivarin (CBDV), Palmitoylethanolamide (PEA)
Phytocannabinoid Source: Not Applicable
Receptors Studied: CB1, CB2, TRPV1, GPCR
